Træk
Weight loss
Reduction of total body weight.
Resumé
- Også kaldet
- Loss of weight
- Kropssystem
- Growth abnormality
ReferencegenomGRCh38hg38
Positioner på gen- og variantsider følger dette valg i denne browser.
Read the genes linked to Weight loss, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test353 gener knyttet til Weight loss
Ændringer i disse gener forårsager sjældne tilstande, hvor Weight loss ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| ABCB7ATP binding cassette subfamily B member 7 | Altid | I 1 tilstand |
| CTNScystinosin, lysosomal cystine transporter | Altid | I 1 tilstand |
| FLNAfilamin A | Altid | I 1 tilstand |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Altid | I 2 tilstande |
| KLF1KLF transcription factor 1 | Altid | I 1 tilstand |
| POLGDNA polymerase gamma, catalytic subunit | Altid | I 4 tilstande |
| PTCRApre T cell antigen receptor alpha | Altid | I 1 tilstand |
| TYMPthymidine phosphorylase | Altid | I 2 tilstande |
| ABCC8ATP binding cassette subfamily C member 8 | Meget ofte (80–99 %) | I 1 tilstand |
| ABCD3ATP binding cassette subfamily D member 3 | Meget ofte (80–99 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Meget ofte (80–99 %) | I 2 tilstande |
| ATP7BATPase copper transporting beta | Meget ofte (80–99 %) | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Meget ofte (80–99 %) | I 1 tilstand |
| BCL10BCL10 immune signaling adaptor | Meget ofte (80–99 %) | I 1 tilstand |
| BCL2BCL2 apoptosis regulator | Meget ofte (80–99 %) | I 1 tilstand |
| BCL6BCL6 transcription repressor | Meget ofte (80–99 %) | I 1 tilstand |
| BIRC3baculoviral IAP repeat containing 3 | Meget ofte (80–99 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Meget ofte (80–99 %) | I 1 tilstand |
| BMPR1Abone morphogenetic protein receptor type 1A | Meget ofte (80–99 %) | I 1 tilstand |
| BRCA1BRCA1 DNA repair associated | Meget ofte (80–99 %) | I 2 tilstande |
| BRCA2BRCA2 DNA repair associated | Meget ofte (80–99 %) | I 4 tilstande |
| C4Acomplement C4A (Chido/Rodgers blood group) | Meget ofte (80–99 %) | I 2 tilstande |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Meget ofte (80–99 %) | I 1 tilstand |
| CDKN2Acyclin dependent kinase inhibitor 2A | Meget ofte (80–99 %) | I 2 tilstande |
| CHEK2checkpoint kinase 2 | Meget ofte (80–99 %) | I 2 tilstande |
| CR2complement C3d receptor 2 | Meget ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Meget ofte (80–99 %) | I 3 tilstande |
| DCTN1dynactin subunit 1 | Meget ofte (80–99 %) | I 3 tilstande |
| DNASE1deoxyribonuclease 1 | Meget ofte (80–99 %) | I 1 tilstand |
| EPCAMepithelial cell adhesion molecule | Meget ofte (80–99 %) | I 2 tilstande |
| ETS1ETS proto-oncogene 1, transcription factor | Meget ofte (80–99 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Meget ofte (80–99 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Meget ofte (80–99 %) | I 1 tilstand |
| FOXP1forkhead box P1 | Meget ofte (80–99 %) | I 1 tilstand |
| GCKglucokinase | Meget ofte (80–99 %) | I 1 tilstand |
| GIPC1GIPC PDZ domain containing family member 1 | Meget ofte (80–99 %) | I 1 tilstand |
| GJA1gap junction protein alpha 1 | Meget ofte (80–99 %) | I 1 tilstand |
| GJB3gap junction protein beta 3 | Meget ofte (80–99 %) | I 1 tilstand |
| GJB4gap junction protein beta 4 | Meget ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Meget ofte (80–99 %) | I 5 tilstande |
Vis 313 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Meget ofte (80–99 %) | I 1 tilstand |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Meget ofte (80–99 %) | I 2 tilstande |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Meget ofte (80–99 %) | I 3 tilstande |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Meget ofte (80–99 %) | I 7 tilstande |
| HLCSholocarboxylase synthetase | Meget ofte (80–99 %) | I 1 tilstand |
| IGHimmunoglobulin heavy locus | Meget ofte (80–99 %) | I 3 tilstande |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Meget ofte (80–99 %) | I 1 tilstand |
| IKZF1IKAROS family zinc finger 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Meget ofte (80–99 %) | I 3 tilstande |
| IL12Binterleukin 12B | Meget ofte (80–99 %) | I 1 tilstand |
| INSinsulin | Meget ofte (80–99 %) | I 1 tilstand |
| IRAK1interleukin 1 receptor associated kinase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Meget ofte (80–99 %) | I 1 tilstand |
| ITGAMintegrin subunit alpha M | Meget ofte (80–99 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Meget ofte (80–99 %) | I 3 tilstande |
| JAZF1JAZF zinc finger 1 | Meget ofte (80–99 %) | I 1 tilstand |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Meget ofte (80–99 %) | I 1 tilstand |
| KDSR3-ketodihydrosphingosine reductase | Meget ofte (80–99 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Meget ofte (80–99 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Meget ofte (80–99 %) | I 2 tilstande |
| KRT1keratin 1 | Meget ofte (80–99 %) | I 1 tilstand |
| KRT10keratin 10 | Meget ofte (80–99 %) | I 1 tilstand |
| LMNAlamin A/C | Meget ofte (80–99 %) | I 1 tilstand |
| LPIN2lipin 2 | Meget ofte (80–99 %) | I 1 tilstand |
| LRP12LDL receptor related protein 12 | Meget ofte (80–99 %) | I 3 tilstande |
| MALT1MALT1 paracaspase | Meget ofte (80–99 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Meget ofte (80–99 %) | I 1 tilstand |
| MLH1mutL homolog 1 | Meget ofte (80–99 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Meget ofte (80–99 %) | I 1 tilstand |
| MSH2mutS homolog 2 | Meget ofte (80–99 %) | I 1 tilstand |
| MSH6mutS homolog 6 | Meget ofte (80–99 %) | I 1 tilstand |
| MUTYHmutY DNA glycosylase | Meget ofte (80–99 %) | I 1 tilstand |
| NOTCH2NLCnotch 2 N-terminal like C | Meget ofte (80–99 %) | I 1 tilstand |
| NPATnuclear protein, coactivator of histone transcription | Meget ofte (80–99 %) | I 1 tilstand |
| NUTM2B-AS1NUTM2B antisense RNA 1 | Meget ofte (80–99 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Meget ofte (80–99 %) | I 1 tilstand |
| PALB2partner and localizer of BRCA2 | Meget ofte (80–99 %) | I 2 tilstande |
| PALLDpalladin, cytoskeletal associated protein | Meget ofte (80–99 %) | I 1 tilstand |
| PDCD1programmed cell death 1 | Meget ofte (80–99 %) | I 1 tilstand |
| PDX1pancreatic and duodenal homeobox 1 | Meget ofte (80–99 %) | I 1 tilstand |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Meget ofte (80–99 %) | I 1 tilstand |
| PMS1PMS1 homolog 1, mismatch repair system component | Meget ofte (80–99 %) | I 1 tilstand |
| PMS2PMS1 homolog 2, mismatch repair system component | Meget ofte (80–99 %) | I 1 tilstand |
| POLD1DNA polymerase delta 1, catalytic subunit | Meget ofte (80–99 %) | I 1 tilstand |
| POLEDNA polymerase epsilon, catalytic subunit | Meget ofte (80–99 %) | I 1 tilstand |
| PRTN3proteinase 3 | Meget ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Meget ofte (80–99 %) | I 4 tilstande |
| PXKPX domain containing serine/threonine kinase like | Meget ofte (80–99 %) | I 1 tilstand |
| RABL3RAB, member of RAS oncogene family like 3 | Meget ofte (80–99 %) | I 1 tilstand |
| RILPL1Rab interacting lysosomal protein like 1 | Meget ofte (80–99 %) | I 1 tilstand |
| RPS20ribosomal protein S20 | Meget ofte (80–99 %) | I 1 tilstand |
| SEMA4Asemaphorin 4A | Meget ofte (80–99 %) | I 1 tilstand |
| SLC5A1solute carrier family 5 member 1 | Meget ofte (80–99 %) | I 1 tilstand |
| SMAD4SMAD family member 4 | Meget ofte (80–99 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Meget ofte (80–99 %) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Meget ofte (80–99 %) | I 2 tilstande |
| STAT4signal transducer and activator of transcription 4 | Meget ofte (80–99 %) | I 3 tilstande |
| TGFBR2transforming growth factor beta receptor 2 | Meget ofte (80–99 %) | I 1 tilstand |
| TLR7toll like receptor 7 | Meget ofte (80–99 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Meget ofte (80–99 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Meget ofte (80–99 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Meget ofte (80–99 %) | I 1 tilstand |
| TP53tumor protein p53 | Meget ofte (80–99 %) | I 3 tilstande |
| TREX1three prime repair exonuclease 1 | Meget ofte (80–99 %) | I 1 tilstand |
| TSHRthyroid stimulating hormone receptor | Meget ofte (80–99 %) | I 2 tilstande |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Meget ofte (80–99 %) | I 1 tilstand |
| ZMPSTE24zinc metallopeptidase STE24 | Meget ofte (80–99 %) | I 1 tilstand |
| AAASaladin WD repeat nucleoporin | Ofte (30–79 %) | I 1 tilstand |
| ABCD1ATP binding cassette subfamily D member 1 | Ofte (30–79 %) | I 1 tilstand |
| ACTA1actin alpha 1, skeletal muscle | Ofte (30–79 %) | I 1 tilstand |
| AK2adenylate kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| ALKALK receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| ANGangiogenin | Ofte (30–79 %) | I 1 tilstand |
| ANO1anoctamin 1 | Ofte (30–79 %) | I 1 tilstand |
| ANXA11annexin A11 | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 2 tilstande |
| ATP7AATPase copper transporting alpha | Ofte (30–79 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Ofte (30–79 %) | I 1 tilstand |
| ATXN2ataxin 2 | Ofte (30–79 %) | I 1 tilstand |
| AVParginine vasopressin | Ofte (30–79 %) | I 1 tilstand |
| B2Mbeta-2-microglobulin | Ofte (30–79 %) | I 1 tilstand |
| BAP1BRCA1 associated deubiquitinase 1 | Ofte (30–79 %) | I 1 tilstand |
| BCORBCL6 corepressor | Ofte (30–79 %) | I 1 tilstand |
| BTNL2butyrophilin like 2 | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Ofte (30–79 %) | I 2 tilstande |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCND1cyclin D1 | Ofte (30–79 %) | I 2 tilstande |
| CCNFcyclin F | Ofte (30–79 %) | I 1 tilstand |
| CDC73cell division cycle 73 | Ofte (30–79 %) | I 1 tilstand |
| CDH23cadherin related 23 | Ofte (30–79 %) | I 1 tilstand |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Ofte (30–79 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Ofte (30–79 %) | I 1 tilstand |
| CFAP410cilia and flagella associated protein 410 | Ofte (30–79 %) | I 1 tilstand |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Ofte (30–79 %) | I 1 tilstand |
| CHMP2Bcharged multivesicular body protein 2B | Ofte (30–79 %) | I 1 tilstand |
| CRLF1cytokine receptor like factor 1 | Ofte (30–79 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Ofte (30–79 %) | I 1 tilstand |
| DAOD-amino acid oxidase | Ofte (30–79 %) | I 1 tilstand |
| DLSTdihydrolipoamide S-succinyltransferase | Ofte (30–79 %) | I 1 tilstand |
| DNMT3ADNA methyltransferase 3 alpha | Ofte (30–79 %) | I 1 tilstand |
| ECE1endothelin converting enzyme 1 | Ofte (30–79 %) | I 1 tilstand |
| EDN3endothelin 3 | Ofte (30–79 %) | I 1 tilstand |
| EDNRBendothelin receptor type B | Ofte (30–79 %) | I 1 tilstand |
| EHHADHenoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase | Ofte (30–79 %) | I 1 tilstand |
| ELF4E74 like ETS transcription factor 4 | Ofte (30–79 %) | I 1 tilstand |
| EPAS1endothelial PAS domain protein 1 | Ofte (30–79 %) | I 1 tilstand |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Ofte (30–79 %) | I 1 tilstand |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Ofte (30–79 %) | I 1 tilstand |
| EWSR1EWS RNA binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| FHfumarate hydratase | Ofte (30–79 %) | I 1 tilstand |
| FIG4FIG4 phosphoinositide 5-phosphatase | Ofte (30–79 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Ofte (30–79 %) | I 1 tilstand |
| FUSFUS RNA binding protein | Ofte (30–79 %) | I 1 tilstand |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Ofte (30–79 %) | I 1 tilstand |
| GATA2GATA binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| GATA4GATA binding protein 4 | Ofte (30–79 %) | I 1 tilstand |
| GATMglycine amidinotransferase | Ofte (30–79 %) | I 1 tilstand |
| GDNFglial cell derived neurotrophic factor | Ofte (30–79 %) | I 1 tilstand |
| GLE1GLE1 RNA export mediator | Ofte (30–79 %) | I 1 tilstand |
| GLT8D1glycosyltransferase 8 domain containing 1 | Ofte (30–79 %) | I 1 tilstand |
| GMPPAGDP-mannose pyrophosphorylase A | Ofte (30–79 %) | I 1 tilstand |
| GPR35G protein-coupled receptor 35 | Ofte (30–79 %) | I 1 tilstand |
| HACD13-hydroxyacyl-CoA dehydratase 1 | Ofte (30–79 %) | I 1 tilstand |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Ofte (30–79 %) | I 1 tilstand |
| HAVCR2hepatitis A virus cellular receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DQA1major histocompatibility complex, class II, DQ alpha 1 | Ofte (30–79 %) | I 2 tilstande |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Ofte (30–79 %) | I 1 tilstand |
| HTThuntingtin | Ofte (30–79 %) | I 2 tilstande |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| ITGA7integrin subunit alpha 7 | Ofte (30–79 %) | I 1 tilstand |
| KIF1Bkinesin family member 1B | Ofte (30–79 %) | I 2 tilstande |
| KITKIT proto-oncogene, receptor tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| LIG3DNA ligase 3 | Ofte (30–79 %) | I 1 tilstand |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Ofte (30–79 %) | I 1 tilstand |
| LMO1LIM domain only 1 | Ofte (30–79 %) | I 1 tilstand |
| MAP3K20mitogen-activated protein kinase kinase kinase 20 | Ofte (30–79 %) | I 1 tilstand |
| MATR3matrin 3 | Ofte (30–79 %) | I 1 tilstand |
| MAXMYC associated transcriptional regulator X | Ofte (30–79 %) | I 1 tilstand |
| MC2Rmelanocortin 2 receptor | Ofte (30–79 %) | I 1 tilstand |
| MDH2malate dehydrogenase 2 | Ofte (30–79 %) | I 1 tilstand |
| MEN1menin 1 | Ofte (30–79 %) | I 1 tilstand |
| MRAPmelanocortin 2 receptor accessory protein | Ofte (30–79 %) | I 1 tilstand |
| MST1macrophage stimulating 1 | Ofte (30–79 %) | I 1 tilstand |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Ofte (30–79 %) | I 1 tilstand |
| MYL2myosin light chain 2 | Ofte (30–79 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NDUFAF6NADH:ubiquinone oxidoreductase complex assembly factor 6 | Ofte (30–79 %) | I 1 tilstand |
| NEFHneurofilament heavy chain | Ofte (30–79 %) | I 1 tilstand |
| NEK1NIMA related kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| NF1neurofibromin 1 | Ofte (30–79 %) | I 1 tilstand |
| NNTnicotinamide nucleotide transhydrogenase | Ofte (30–79 %) | I 1 tilstand |
| NOD2nucleotide binding oligomerization domain containing 2 | Ofte (30–79 %) | I 2 tilstande |
| NOS1nitric oxide synthase 1 | Ofte (30–79 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Ofte (30–79 %) | I 1 tilstand |
| NRTNneurturin | Ofte (30–79 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Ofte (30–79 %) | I 1 tilstand |
| OPTNoptineurin | Ofte (30–79 %) | I 1 tilstand |
| PFN1profilin 1 | Ofte (30–79 %) | I 1 tilstand |
| PHOX2Bpaired like homeobox 2B | Ofte (30–79 %) | I 1 tilstand |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Ofte (30–79 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ofte (30–79 %) | I 2 tilstande |
| PRPHperipherin | Ofte (30–79 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| RETret proto-oncogene | Ofte (30–79 %) | I 3 tilstande |
| RHBDF2rhomboid 5 homolog 2 | Ofte (30–79 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Ofte (30–79 %) | I 2 tilstande |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Ofte (30–79 %) | I 3 tilstande |
| SDHAF1succinate dehydrogenase complex assembly factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SDHAF2succinate dehydrogenase complex assembly factor 2 | Ofte (30–79 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Ofte (30–79 %) | I 4 tilstande |
| SDHCsuccinate dehydrogenase complex subunit C | Ofte (30–79 %) | I 2 tilstande |
| SDHDsuccinate dehydrogenase complex subunit D | Ofte (30–79 %) | I 4 tilstande |
| SELENONselenoprotein N | Ofte (30–79 %) | I 1 tilstand |
| SEMA3Csemaphorin 3C | Ofte (30–79 %) | I 1 tilstand |
| SEMA3Dsemaphorin 3D | Ofte (30–79 %) | I 1 tilstand |
| SEMA4Dsemaphorin 4D | Ofte (30–79 %) | I 1 tilstand |
| SLC25A11solute carrier family 25 member 11 | Ofte (30–79 %) | I 1 tilstand |
| SLC2A3solute carrier family 2 member 3 | Ofte (30–79 %) | I 1 tilstand |
| SLC34A1solute carrier family 34 member 1 | Ofte (30–79 %) | I 1 tilstand |
| SMOsmoothened, frizzled class receptor | Ofte (30–79 %) | I 1 tilstand |
| SOD1superoxide dismutase 1 | Ofte (30–79 %) | I 1 tilstand |
| SQSTM1sequestosome 1 | Ofte (30–79 %) | I 1 tilstand |
| SREBF1sterol regulatory element binding transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 2 tilstande |
| STARsteroidogenic acute regulatory protein | Ofte (30–79 %) | I 1 tilstand |
| STAT1signal transducer and activator of transcription 1 | Ofte (30–79 %) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Ofte (30–79 %) | I 1 tilstand |
| SYKspleen associated tyrosine kinase | Ofte (30–79 %) | I 1 tilstand |
| TAF15TATA-box binding protein associated factor 15 | Ofte (30–79 %) | I 1 tilstand |
| TARDBPTAR DNA binding protein | Ofte (30–79 %) | I 1 tilstand |
| TBK1TANK binding kinase 1 | Ofte (30–79 %) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Ofte (30–79 %) | I 1 tilstand |
| TCF4transcription factor 4 | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstande |
| TMEM127transmembrane protein 127 | Ofte (30–79 %) | I 1 tilstand |
| TPM2tropomyosin 2 | Ofte (30–79 %) | I 1 tilstand |
| TPM3tropomyosin 3 | Ofte (30–79 %) | I 1 tilstand |
| TRAPPC11trafficking protein particle complex subunit 11 | Ofte (30–79 %) | I 1 tilstand |
| TREM2triggering receptor expressed on myeloid cells 2 | Ofte (30–79 %) | I 1 tilstand |
| TTRtransthyretin | Ofte (30–79 %) | I 1 tilstand |
| TXNRD2thioredoxin reductase 2 | Ofte (30–79 %) | I 1 tilstand |
| UBQLN2ubiquilin 2 | Ofte (30–79 %) | I 1 tilstand |
| UNC13Aunc-13 homolog A | Ofte (30–79 %) | I 1 tilstand |
| VAPBVAMP associated protein B and C | Ofte (30–79 %) | I 1 tilstand |
| VCPvalosin containing protein | Ofte (30–79 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Ofte (30–79 %) | I 2 tilstande |
| WT1WT1 transcription factor | Ofte (30–79 %) | I 2 tilstande |
| ZBTB16zinc finger and BTB domain containing 16 | Ofte (30–79 %) | I 1 tilstand |
| ZNRF3zinc and ring finger 3 | Ofte (30–79 %) | I 1 tilstand |
| ACAT1acetyl-CoA acetyltransferase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| AMNamnion associated transmembrane protein | Nogle gange (5–29 %) | I 1 tilstand |
| ANKRD55ankyrin repeat domain 55 | Nogle gange (5–29 %) | I 1 tilstand |
| BMP6bone morphogenetic protein 6 | Nogle gange (5–29 %) | I 1 tilstand |
| BRIP1BRCA1 interacting DNA helicase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| BTKBruton tyrosine kinase | Nogle gange (5–29 %) | I 1 tilstand |
| CALRcalreticulin | Nogle gange (5–29 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Nogle gange (5–29 %) | I 1 tilstand |
| CD247CD247 molecule | Nogle gange (5–29 %) | I 1 tilstand |
| COL4A5collagen type IV alpha 5 chain | Nogle gange (5–29 %) | I 1 tilstand |
| COL4A6collagen type IV alpha 6 chain | Nogle gange (5–29 %) | I 1 tilstand |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Nogle gange (5–29 %) | I 1 tilstand |
| CTRCchymotrypsin C | Nogle gange (5–29 %) | I 1 tilstand |
| CUBNcubilin | Nogle gange (5–29 %) | I 1 tilstand |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Nogle gange (5–29 %) | I 1 tilstand |
| DNAJC13DnaJ heat shock protein family (Hsp40) member C13 | Nogle gange (5–29 %) | I 1 tilstand |
| EIF4G1eukaryotic translation initiation factor 4 gamma 1 | Nogle gange (5–29 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Nogle gange (5–29 %) | I 1 tilstand |
| F5coagulation factor V | Nogle gange (5–29 %) | I 1 tilstand |
| FAAP100FA core complex associated protein 100 | Nogle gange (5–29 %) | I 1 tilstand |
| FANCAFA complementation group A | Nogle gange (5–29 %) | I 1 tilstand |
| FANCBFA complementation group B | Nogle gange (5–29 %) | I 1 tilstand |
| FANCCFA complementation group C | Nogle gange (5–29 %) | I 1 tilstand |
| FANCD2FA complementation group D2 | Nogle gange (5–29 %) | I 1 tilstand |
| FANCEFA complementation group E | Nogle gange (5–29 %) | I 1 tilstand |
| FANCFFA complementation group F | Nogle gange (5–29 %) | I 1 tilstand |
| FANCGFA complementation group G | Nogle gange (5–29 %) | I 1 tilstand |
| FANCIFA complementation group I | Nogle gange (5–29 %) | I 1 tilstand |
| FANCLFA complementation group L | Nogle gange (5–29 %) | I 1 tilstand |
| FANCMFA complementation group M | Nogle gange (5–29 %) | I 1 tilstand |
| FASFas cell surface death receptor | Nogle gange (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Nogle gange (5–29 %) | I 1 tilstand |
| GALCgalactosylceramidase | Nogle gange (5–29 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Nogle gange (5–29 %) | I 1 tilstand |
| GIGYF2GRB10 interacting GYF protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Nogle gange (5–29 %) | I 1 tilstand |
| GPC3glypican 3 | Nogle gange (5–29 %) | I 1 tilstand |
| H19H19 imprinted maternally expressed transcript | Nogle gange (5–29 %) | I 1 tilstand |
| HFEhomeostatic iron regulator | Nogle gange (5–29 %) | I 1 tilstand |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Nogle gange (5–29 %) | I 1 tilstand |
| IFIH1interferon induced with helicase C domain 1 | Nogle gange (5–29 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Nogle gange (5–29 %) | I 2 tilstande |
| IL12Ainterleukin 12A | Nogle gange (5–29 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Nogle gange (5–29 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Nogle gange (5–29 %) | I 1 tilstand |
| IL2RAinterleukin 2 receptor subunit alpha | Nogle gange (5–29 %) | I 1 tilstand |
| IL2RBinterleukin 2 receptor subunit beta | Nogle gange (5–29 %) | I 1 tilstand |
| IVDisovaleryl-CoA dehydrogenase | Nogle gange (5–29 %) | I 1 tilstand |
| JPH3junctophilin 3 | Nogle gange (5–29 %) | I 2 tilstande |
| KLRC4killer cell lectin like receptor C4 | Nogle gange (5–29 %) | I 1 tilstand |
| LRRK2leucine rich repeat kinase 2 | Nogle gange (5–29 %) | I 1 tilstand |
| MAD2L2mitotic arrest deficient 2 like 2 | Nogle gange (5–29 %) | I 1 tilstand |
| MAP2K1mitogen-activated protein kinase kinase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Nogle gange (5–29 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Nogle gange (5–29 %) | I 1 tilstand |
| NAB2NGFI-A binding protein 2 | Nogle gange (5–29 %) | I 1 tilstand |
| NR0B1nuclear receptor subfamily 0 group B member 1 | Nogle gange (5–29 %) | I 1 tilstand |
| NRASNRAS proto-oncogene, GTPase | Nogle gange (5–29 %) | I 1 tilstand |
| PANK2pantothenate kinase 2 | Nogle gange (5–29 %) | I 1 tilstand |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Nogle gange (5–29 %) | I 1 tilstand |
| POU6F2POU class 6 homeobox 2 | Nogle gange (5–29 %) | I 1 tilstand |
| PRNPprion protein (Kanno blood group) | Nogle gange (5–29 %) | I 4 tilstande |
| PSAPprosaposin | Nogle gange (5–29 %) | I 1 tilstand |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Nogle gange (5–29 %) | I 1 tilstand |
| RAD51RAD51 recombinase | Nogle gange (5–29 %) | I 1 tilstand |
| RAD51CRAD51 paralog C | Nogle gange (5–29 %) | I 1 tilstand |
| RESTRE1 silencing transcription factor | Nogle gange (5–29 %) | I 1 tilstand |
| RFWD3ring finger and WD repeat domain 3 | Nogle gange (5–29 %) | I 1 tilstand |
| RNF168ring finger protein 168 | Nogle gange (5–29 %) | I 1 tilstand |
| RNU7-1RNA, U7 small nuclear 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SCNN1Asodium channel epithelial 1 subunit alpha | Nogle gange (5–29 %) | I 1 tilstand |
| SCNN1Bsodium channel epithelial 1 subunit beta | Nogle gange (5–29 %) | I 1 tilstand |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Nogle gange (5–29 %) | I 1 tilstand |
| SLC34A2solute carrier family 34 member 2 | Nogle gange (5–29 %) | I 1 tilstand |
| SLC39A4solute carrier family 39 member 4 | Nogle gange (5–29 %) | I 1 tilstand |
| SLX4SLX4 structure-specific endonuclease subunit | Nogle gange (5–29 %) | I 1 tilstand |
| SNCAsynuclein alpha | Nogle gange (5–29 %) | I 2 tilstande |
| SPINK1serine peptidase inhibitor Kazal type 1 | Nogle gange (5–29 %) | I 1 tilstand |
| STAT6signal transducer and activator of transcription 6 | Nogle gange (5–29 %) | I 1 tilstand |
| THPOthrombopoietin | Nogle gange (5–29 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Nogle gange (5–29 %) | I 1 tilstand |
| TRIM28tripartite motif containing 28 | Nogle gange (5–29 %) | I 1 tilstand |
| TRIP13thyroid hormone receptor interactor 13 | Nogle gange (5–29 %) | I 1 tilstand |
| TWNKtwinkle mtDNA helicase | Nogle gange (5–29 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Nogle gange (5–29 %) | I 1 tilstand |
| UBE2Tubiquitin conjugating enzyme E2 T | Nogle gange (5–29 %) | I 1 tilstand |
| UNC45Aunc-45 myosin chaperone A | Nogle gange (5–29 %) | I 1 tilstand |
| VPS13Avacuolar protein sorting 13 homolog A | Nogle gange (5–29 %) | I 1 tilstand |
| VPS35VPS35 retromer complex component | Nogle gange (5–29 %) | I 1 tilstand |
| XRCC2X-ray repair cross complementing 2 | Nogle gange (5–29 %) | I 1 tilstand |
| CD28CD28 molecule | Sjældent (1–4%) | I 1 tilstand |
| RB1RB transcriptional corepressor 1 | Sjældent (1–4%) | I 1 tilstand |
| TNFRSF1BTNF receptor superfamily member 1B | Sjældent (1–4%) | I 1 tilstand |
| CD244CD244 molecule | Ikke registreret | I 1 tilstand |
| CIITAclass II major histocompatibility complex transactivator | Ikke registreret | I 1 tilstand |
| CYP24A1cytochrome P450 family 24 subfamily A member 1 | Ikke registreret | I 1 tilstand |
| IL6interleukin 6 | Ikke registreret | I 1 tilstand |
| NFKBIL1NFKB inhibitor like 1 | Ikke registreret | I 1 tilstand |
| SLC22A4solute carrier family 22 member 4 | Ikke registreret | I 1 tilstand |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Snævrere træk
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger